1xap
From Proteopedia
Line 1: | Line 1: | ||
[[Image:1xap.jpg|left|200px]] | [[Image:1xap.jpg|left|200px]] | ||
- | + | <!-- | |
- | + | The line below this paragraph, containing "STRUCTURE_1xap", creates the "Structure Box" on the page. | |
- | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
- | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
- | | | + | or leave the SCENE parameter empty for the default display. |
- | | | + | --> |
- | + | {{STRUCTURE_1xap| PDB=1xap | SCENE= }} | |
- | + | ||
- | + | ||
- | }} | + | |
'''Structure of the ligand binding domain of the Retinoic Acid Receptor beta''' | '''Structure of the ligand binding domain of the Retinoic Acid Receptor beta''' | ||
Line 37: | Line 34: | ||
[[Category: Tortolani, D.]] | [[Category: Tortolani, D.]] | ||
[[Category: Zusi, F C.]] | [[Category: Zusi, F C.]] | ||
- | [[Category: | + | [[Category: Ligand binding domain]] |
- | [[Category: | + | [[Category: Nuclear receptor]] |
- | [[Category: | + | [[Category: Retinoic acid receptor beta]] |
- | [[Category: | + | [[Category: Ttnpb]] |
- | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 14:47:29 2008'' | |
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + |
Revision as of 11:47, 3 May 2008
Structure of the ligand binding domain of the Retinoic Acid Receptor beta
Overview
The crystal structure of the ligand-binding domain of RARbeta, a suspect tumour suppressor, reveals important features that distinguish it from the two other RAR isotypes. The most striking difference is an extra cavity allowing RARbeta to bind more bulky agonists. Accordingly, we identified a ligand that shows RARbeta selectivity with a 100-fold higher affinity to RARbeta than to alpha or gamma isotypes. The structural differences between the three RAR ligand-binding pockets revealed a rationale explaining how a single retinoid can be at the same time an RARalpha, gamma antagonist and an RARbeta agonist. In addition, we demonstrate how to generate an RARbeta antagonist by gradually modifying the bulkiness of a single substitution. Together, our results provide structural guidelines for the synthesis of RARbeta-selective agonists and antagonists, allowing for the first time to address pharmacologically the tumour suppressor role of RARbeta in vitro and in animal models.
About this Structure
1XAP is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Rational design of RAR-selective ligands revealed by RARbeta crystal stucture., Germain P, Kammerer S, Perez E, Peluso-Iltis C, Tortolani D, Zusi FC, Starrett J, Lapointe P, Daris JP, Marinier A, de Lera AR, Rochel N, Gronemeyer H, EMBO Rep. 2004 Sep;5(9):877-82. PMID:15319780 Page seeded by OCA on Sat May 3 14:47:29 2008
Categories: Homo sapiens | Single protein | Daris, J P. | Germain, P. | Gronemeyer, H. | Kammerer, S. | Lapointe, P. | Lera, A R.De. | Marinier, A. | Peluso-Iltis, C. | Rochel, N. | Starrett, J. | Tortolani, D. | Zusi, F C. | Ligand binding domain | Nuclear receptor | Retinoic acid receptor beta | Ttnpb